B07: SAFETY AND EFFICACY OF CILTACABTAGENE AUTOLEUCEL, A CHIMERIC ANTIGEN RECEPTOR T-CELL THERAPY DIRECTED AGAINST B-CELL MATURATION ANTIGEN IN PATIENTS WITH MULTIPLE MYELOMA AND EARLY RELAPSE AFTER INITIAL THERAPY: CARTITUDE-2 RESULTS. (5th April 2022) - van de Donk, NWCJ; Delforge, M; Agha, M; Cohen, AD; Cohen, YC; Hillengass, J; Anguille, S; Kerre, T; Roeloffzen, W; Schecter, JM; De Braganca, KC; Varsos, H; et al.